PharmAthene to Present at the ROTH Capital Partners 23rd Annual Growth Stock Conference on March 14, 2011

Mar 11, 2011, 10:43 ET from PharmAthene, Inc.

ANNAPOLIS, Md., March 11, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that Dr. Thomas Fuerst, Executive Vice President and Chief Scientific Officer for PharmAthene will present at the ROTH Capital Partners 23rd Annual Growth Stock Conference.  The Company is scheduled to present on Monday, March 14, 2011 at 4:00 p.m. Pacific Time at the Ritz Carlton, Laguna Niguel, CA. The presentation will be webcast and can be accessed at PharmAthene's website under the Investor Relations section.

SOURCE PharmAthene, Inc.



RELATED LINKS

http://www.pharmathene.com